Gentiae Clinical Research, Inc., the leader in comprehensive cardiac assessment services, announced today the commencement of a major $1.1M thorough QT study (TQT) on behalf of a Top 10 Biotech company.
Gentiae Clinical Research, Inc., the leader in comprehensive cardiac assessment services, announced today the commencement of a major $1.1M thorough QT study (TQT) on behalf of a Top 10 Biotech company.